The cost of comorbidities in treatment for HIV/AIDS in California.
BACKGROUND:Antiretroviral therapy has increased longevity for people living with HIV (PLWH). As a result, PLWH increasingly experience the common diseases of aging and the resources needed to manage these comorbidities are increasing. This paper characterizes the number and types of comorbidities di...
Main Authors: | David S Zingmond, Kodi B Arfer, Jennifer L Gildner, Arleen A Leibowitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5730113?pdf=render |
Similar Items
-
Do Medicare Beneficiaries Living With HIV/AIDS Choose Prescription Drug Plans That Minimize Their Total Spending?
by: Katherine A. Desmond MS, et al.
Published: (2017-10-01) -
Initial Health Assessments and HIV Screening under the Affordable Care Act.
by: Arleen A Leibowitz, et al.
Published: (2015-01-01) -
Cost of noninfectious comorbidities in patients with HIV
by: Guaraldi G, et al.
Published: (2013-09-01) -
Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities
by: Thomas Awamura, et al.
Published: (2023-11-01) -
Comorbidities and co-infections in people living with HIV/AIDS
by: Rosângela Casas Righetto, et al.
Published: (2015-02-01)